Shima, Midori
Article History
Received: 27 November 2022
Accepted: 19 May 2023
First Online: 30 June 2023
Declarations
:
: This article does not contain any studies with animals performed by any of the authors.
: Not applicable.
: Midori Shima reports participation on advisory board for Chugai, Fujimoto Seiyaku, speaker fee and honorarium from Chugai, Roche, CSL-Behring, Fujimoto Seiyaku, Sanofi, Pfizer, Takeda, Novo Nordisk, Bayer and research funding from CSL-Behring and Takeda.